Trademark: 79339480
Word
NOVILUX
Status Date
Tuesday, July 23, 2024
Filing Date
Wednesday, February 9, 2022
Published for Opposition
Tuesday, July 23, 2024
9 Recorded and downloadable software to be used in the field of rapid clinical and diagnostic testing for measurement of in vitro coagulation and platelet function in bodily fluids, and for determining the presence of anti-coagulants and platelet inhibitors in bodily fluids
May 10, 2022
Limitation From Original Application Entered
May 5, 2022
Sn Assigned For Sect 66a Appl From Ib
May 12, 2022
New Application Office Supplied Data Entered
May 17, 2022
Application Filing Receipt Mailed
Aug 13, 2022
New Representative At Ib Received
Nov 22, 2022
Assigned To Examiner
Dec 1, 2022
Non-Final Action Written
Dec 2, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jan 28, 2023
Refusal Processed By Mpu
Jan 28, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Feb 21, 2023
Refusal Processed By Ib
Jul 28, 2023
Teas Response To Office Action Received
Jul 28, 2023
Correspondence Received In Law Office
Jul 31, 2023
Teas/Email Correspondence Entered
Oct 11, 2023
Notification Of Possible Opposition Sent To Ib
Oct 11, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Oct 31, 2023
Notification Of Possible Opposition - Processed By Ib
Jun 14, 2024
Examiners Amendment -Written
Jun 14, 2024
Examiners Amendment E-Mailed
Jun 14, 2024
Approved For Pub - Principal Register
Jun 14, 2024
Notification Of Examiners Amendment E-Mailed
Jun 14, 2024
Examiner's Amendment Entered
Jul 3, 2024
Notification Of Notice Of Publication E-Mailed
Jul 23, 2024
Published For Opposition
Jul 23, 2024
Official Gazette Publication Confirmation E-Mailed
Dec 1, 2023
Notification Of Final Refusal Emailed
Dec 1, 2023
Final Refusal Written
Dec 1, 2023
Final Refusal E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
